Product Images Gabapentin

The text describes a graph showing the weekly mean pain scores observed in a population during a study. The study involved a 3-week period of dose titration, followed by a fixed dose period of an unknown length. The graph shows three groups: placebo, gabapentin at 1800 mg/day, and gabapentin at 2400 mg/day. The mean pain scores are indicated on the Y-axis and the weeks of the study on the X-axis. The results show that gabapentin at both 1800 mg/day and 2400 mg/day significantly reduced pain compared to placebo.*

The text shows a chart or graph that presents the proportion of responders in controlled PHN studies. The data shows percentages ranging from 0% to 100%, with higher percentages indicating more patients experiencing greater than 50% reduction in pain score. The chart has two studies marked Study 1 and Study 2, with multiple drug options and placebo being used. However, some characters are not readable in the text, making it challenging to provide an accurate description.*

This is a medication description for Gabapentin 300mg in a bottle containing 30 capsules. The medicine is manufactured by Solco Healthcare US.LLG and repackaged by MSM Repackaging. The lot number is 01MSM-266-GM5029, and the product's expiration date is not available. It can only be obtained through a prescription. The usual dosage and storage conditions can be found in the package insert.*